In This Section

Home / Learn / Cancer Types / Breast Cancer

Breast Cancer

Breast cancer accounts for approximately 30 percent of all new cancers in the United States. Estimates show 288,000 new cases of invasive breast cancer will be diagnosed annually. Risk for breast cancer increases with age, but is also dependent on other factors such as genetic mutations, health history, etc. Breast cancer variations also occur depending on race and ethnicity.

Advances in early detection and treatment have helped to reduce breast cancer mortality, however disparities remain among cancer patients. ACCC education programs examine the latest multidisciplinary education and resources regarding health disparities in breast cancer care, the latest clinical advances, and initiatives that aim to improve the quality of breast cancer patient care.

Metastatic Breast Cancer Resources

While breast cancer is a high-profile disease, receiving significant private and public research funding and focused awareness and prevention initiatives, patients with metastatic breast cancer face unique challenges.

Multidisciplinary Breast Cancer Resources

ACCC supports multidisciplinary breast cancer care teams with education and resources in areas such as HR+, HER2-, HER2+, Triple Negative, and BRCA testing.

Supportive Care Strategies for Promoting Health Equity in Patients with Breast Cancer

Access ACCC resources to address barriers to supportive oncology services for underserved populations with breast cancer.

On-Demand Webinars

Cancer Buzz Podcasts

  • Improving Care Delivery to Patients Newly Diagnosed with Breast Cancer – [Podcast] Ep 151
    May 3, 2024

    Addressing this issue required a coordinated, multidisciplinary approach that involved engaging the cancer center leadership across 3 treatment departments—medical, radiation, and surgical oncology—administration, physicians, advanced practice providers (APPs), patient navigation, genetic counseling, scheduling, imaging, lab, and pathology. The primary goals of the initiative were to transform patient experience and improve timeliness to care for every newly diagnosed patient.

  • A New Registry Study for a Rare Form of Breast Cancer — [PODCAST] EP 116
    Jun 15, 2023
    Working under the hypothesis that a subset of de novo oligometastatic breast cancer patients who are treated with a combination of systemic therapy, surgery, and radiation or ablation of metastatic sites will have long-term distant metastasis free and overall survival, this multi-cohort, prospective, nationwide registry study will enroll newly diagnosed oligometastatic HER2+ breast cancer patients.
  • Financial Barriers to Oral Cancer Therapies — [Vodcast] Ep 19
    Oct 19, 2022

    Tune-in as our expert discusses how and when to screen patients, and then connect them to available resources to better support patients’ financial needs.

From Oncology Issues